Donated Does Not Mean Free

The Long Journey from Tissue Donation to the Operating Room

Every year, thousands of patients receive life-changing procedures using donated human tissue. Bone grafts help achieve spinal fusion. Tendons restore knee stability. Placental tissues support wound healing.

Yet one question inevitably arises whenever allografts enter the conversation:

If the tissue was donated, why does it cost so much?

The answer is both simple and surprisingly complex. Human tissue itself is never sold. In the United States, federal law prohibits the commercialization of human body parts. What hospitals and surgeons pay for is not the tissue itself, but the enormous infrastructure required to make that tissue safe, traceable, and usable in modern medicine.

To understand why allograft costs what it does, it helps to follow the journey of a single donor.

A Donor’s Gift Begins with Consent

The process usually begins as agreeing to be a Organ Donor on your drivers license or in a hospital, often after the death of a patient who has registered as a donor or whose family authorizes donation.

Specialists from an organ procurement organization (OPO) or tissue bank approach the family to discuss donation. These conversations are handled by trained professionals and are carefully regulated. The family must understand what tissues may be recovered and how they may be used.

Once authorization is obtained, the real work begins.

Donor Clearance: Hundreds of Pages Before a Single Graft

Before the processing begins, usually the donor must be cleared medically and legally. This step alone can involve large teams of specialists reviewing extensive documentation.

A final d onor eligibility determination typically includes:

• Medical history review

• Behavioral risk screening

• Next-of-kin interviews

• Hospital medical record analysis

• Autopsy reports when available

• Infectious disease testing

• Physician review and final clearance

A single donor file can contain hundreds of pages of documentation. This is required to comply with FDA regulations governing human cells, tissues, and cellular and tissue-based products (HCT/Ps).

Only when the donor receives final clearance can the tissue be distributed.

Tissue Recovery: A Surgical Procedure

Recovery is performed in an operating room or surgical recovery suite under sterile conditions.

Depending on the tissue bank’s operating model, recovery may be performed by:

• OPO's

• Dedicated recovery teams employed by the tissue bank itself

Some organizations, such as Musculoskeletal Transplant Foundation (MTF), operate their own recovery programs. Others receive recovered tissue from procurement partners.

Either way, recovery requires surgical teams, equipment, transportation logistics, and careful documentation. The recovered tissue is then transported to a processing facility.

This is the point where costs begin to accumulate.

Testing and Quarantine

Recovered tissue does not immediately enter the medical supply chain. Instead, it often enters quarantine.

Samples are taken and tested for infectious diseases using serology and nucleic acid testing. Microbiological cultures assess contamination levels. Final sterility is tested.

Only after all testing is complete and the donor’s eligibility determination is finalized can tissue move forward in the process.

A significant portion of recovered tissue never makes it into circulation.

Processing: Turning Tissue into a Medical Product

At the processing facility, donated tissue undergoes a series of highly controlled procedures designed to make it safe and usable.

Depending on the graft type, processing may include:

• Cleaning and washing

• Decellularization

• Demineralization (for DBM products)

• Lipid removal

• Sterilization procedures

• Shaping and sizing of grafts

• Freeze-drying or cryopreservation

Processing occurs in specialized clean rooms that resemble pharmaceutical manufacturing environments more than traditional surgical facilities.

Technicians follow validated protocols, and each step is carefully documented to comply with regulatory requirements.

Yield: The Invisible Driver of Cost

One of the most important economic realities in tissue banking is yield per donor.

Many of the costs associated with tissue banking occur regardless of how many grafts are ultimately produced from a donor. Donor screening, recovery teams, regulatory documentation, testing, and facility overhead all occur before the final graft count is known.

If contamination, tissue quality, or processing limitations reduce the number of usable grafts, the cost of the entire process must be distributed across fewer products.

In other words, the economics of tissue banking are driven as much by what cannot be used as by what can.

Storage and Distribution

Once processed, grafts must be stored under controlled conditions until they are needed clinically.

Storage requirements vary widely depending on the graft:

• Freeze-dried grafts may be stored at room temperature

• Frozen grafts require specialized freezer infrastructure

• Cryopreserved tissues require ultra-low temperature storage

Each graft must also be tracked through a strict chain-of-custody system to ensure traceability from donor to recipient and back again if necessary.

This traceability system is another key component of regulatory compliance.

Processing Fees, Not Tissue Sales

By the time a graft reaches a hospital, it has passed through a complex system involving surgeons, recovery teams, laboratory specialists, regulatory experts, and manufacturing technicians.

The hospital does not pay for the tissue itself. Instead, it pays a processing and distribution fee that reflects the cumulative cost of:

• donor identification and consent

• donor clearance and screening

• surgical recovery

• testing and quarantine

• processing and sterilization

• storage

• distribution

• regulatory compliance

The donor’s gift is the beginning of the process, but the modern tissue banking system required to deliver that gift safely to patients is extensive.

The Real Value of Donation

Understanding this process does not diminish the extraordinary generosity of donors and their families. In fact, it highlights just how much effort goes into honoring that gift.

Behind every allograft used in surgery is an entire ecosystem of professionals working to ensure that donated tissue is handled safely, ethically, and responsibly.

The tissue may be donated-Everything required to transform it into a safe medical product is not.

In the next article in this series, we will examine the economics of nonprofit tissue banks and why “not-for-profit” does not mean “no profit” in the world of tissue donation.